Catalog No.
DQB91701
Expression system
Mammalian Cells
Species reactivity
Dog
Host species
Caninized
Isotype
IgG2, lambda
Clonality
Monoclonal
Target
NGF/Beta-NGF
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
F1PDQ3
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
ZTS-00508841, CAS: 2171034-69-6
Clone ID
Bedinvetmab
Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)., PMID:40417367
Global pharmacovigilance reporting of the first monoclonal antibody for canine osteoarthritis: a case study with bedinvetmab (Librela™)., PMID:40343372
A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis., PMID:40196808
Answer re: A case of potential rapidly progressing osteoarthritis (RPOA) in a dog under bedinvetmab treatment., PMID:40158904
Re: Iff I, Hohermuth B, Bass D, Bass M. A case of potential rapidly progressing osteoarthritis (RPOA) in a dog during bedinvetmab treatment. Veterinary Anaesthesia and Analgesia. 2024 Nov 29., PMID:40155266
Response to: Iff I, Hohermuth B, Bass D, Bass M (2025) A case of potential rapidly progressing osteoarthritis (RPOA) in a dog during bedinvetmab treatment. Vet Anesth Analg 52, 263-265., PMID:40155265
A Generic Detection Method for the Doping Control Analysis of Fc-Fusion Proteins and Monoclonal Antibodies in Equine Plasma., PMID:40033065
A case of potential rapidly progressing osteoarthritis in a dog during bedinvetmab treatment., PMID:39909782
Measuring the effect of the anti-nerve growth factor antibodies bedinvetmab and frunevetmab on quality of life in dogs and cats with osteoarthritis using a validated health-related quality of life outcome measure: an observational real-world study., PMID:39205806
Use of Bedinvetmab (Librela®) for Canine Osteoarthritis in France, Germany, Italy, Spain, and the UK: Quantitative Analysis of Veterinarian Satisfaction and Real-World Treatment Patterns., PMID:39123757
Re: Re: Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs., PMID:38885831
Re: Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs., PMID:38580157
A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody., PMID:37541934
[New drugs for small animals in 2021]., PMID:35790168
A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis., PMID:34565678
Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs., PMID:34391918
For research use only. Not for human or drug use.
